We anticipate that the hypertriglyceridemia and hypercholesterolemia noticed in Cd-treated animals were attributed to the reduced activity of plasma lipoprotein lipase, a pivotal enzyme, in their breakdown (Larregle et al., 2008). The gene discussed is LPL; the disease is hypertriglyceridemia.